Literature DB >> 15303793

Impetigo herpetiformis in a primigravida: successful treatment with etretinate.

Iqbal A Bukhari1.   

Abstract

Impetigo herpetiformis (IH) is a rare dermatosis which usually occurs during the third trimester of pregnancy. It is characterized by acute erythematosquamous plaques covered with tiny superficial pustules in a herpetiform distribution with less likely mucus membranes involvement. It can be associated with constitutional symptom s such as fever, chills, nausea, vomiting and diarrhea. Impetigo herpetiformis can cause serious complications to the mother and fetus which include: maternal hypocalcemia leading to delirium, convulsions, and tetany in the mother, and placental insufficiency leading to still birth, neonatal death or fetal abnormalities. Lesions are expected to disappear after birth but may recur during subsequent pregnancies at an earlier gestational age. Presented here is a case of IH occurring during the 37th week of gestation in a primigravida who failed to respond to oral steroid but successfully cleared with oral etretinate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15303793

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  3 in total

Review 1.  Autoinflammatory pustular neutrophilic diseases.

Authors:  Haley B Naik; Edward W Cowen
Journal:  Dermatol Clin       Date:  2013-06-02       Impact factor: 3.478

Review 2.  Impetigo Herpetiformis: Review of Pathogenesis, Complication, and Treatment.

Authors:  Nastaran Namazi; Sahar Dadkhahfar
Journal:  Dermatol Res Pract       Date:  2018-04-04

3.  Recurrent impetigo herpetiformis: case report.

Authors:  Emmanuel Wekesa Wamalwa
Journal:  Pan Afr Med J       Date:  2017-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.